Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s Disease

Objectives: Fatigue is a complaint frequently encountered among patients with Parkinson’s disease (PD). Considering the possible relationship between fatigue and dopaminergic dysfuncion, we investigated the effect of pergolide mesilate (a D2 and D1 dopamine receptor agonist) and bromocriptine (a D2...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Kazuo, Takanashi, Mayako, Yanagihara, Takehiko, Sakoda, Sabro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2002
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507127/
https://www.ncbi.nlm.nih.gov/pubmed/12446951
http://dx.doi.org/10.1155/2002/473140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507127/
https://www.ncbi.nlm.nih.gov/pubmed/12446951
http://dx.doi.org/10.1155/2002/473140

Ejemplares similares